ReviewMultiple sclerosis international2023

Brain Atrophy as an Outcome of Disease-Modifying Therapy for Remitting-Relapsing Multiple Sclerosis.

Magdalena Chylińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.